Cécile Thomas Pintière

Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use

N. Rioux-Leclercq, J. Patard, Anne-Sophie Thirouard, 2003, Cancer Immunology, Immunotherapy.

Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients

K. Boudjema, J. Mönkkönen, V. Lavoué, 2010, Cancer Immunology, Immunotherapy.